Lipids that wind down inflammation could be a critical therapeutic tool for MS April 27, 2022 3:05 pm https://www.fiercebiotech.com/biotech/lipids-involved-resolving-inflammation-could-be-critical-therapeutic-tool-ms

After Amgen deal, Plexium maintains momentum with AbbVie neurological partnership April 27, 2022 12:47 pm https://www.fiercebiotech.com/biotech/plexium-maintains-its-momentum-new-abbvie-partnership-focused-neurological-diseases

Future shaky at Solid Bio as it shaves off 35% of workforce, chief operating officer plans exit April 27, 2022 6:47 am https://www.fiercebiotech.com/biotech/future-shaky-solid-bio-it-shaves-35-workforce-chief-operating-officer-plans-exit

BridgeBio strategy head departs amid company’s second round of layoffs this year April 27, 2022 6:39 am https://www.fiercebiotech.com/biotech/bridgebio-strategy-head-departs-amid-companys-second-round-layoffs-year

2 become 1: Caladrius and Cend merge into tumor-focused Lisata Therapeutics April 27, 2022 5:41 am https://www.fiercebiotech.com/biotech/two-become-one-caladrius-and-cend-merge-tumor-focused-lisata-therapeutics

Cytovia inks SPAC merger to get natural killer cells prospects into the clinic April 27, 2022 5:21 am https://www.fiercebiotech.com/biotech/cytovia-inks-spac-merger-get-natural-killer-cells-prospects-clinic

Spying synthetic lethal promise, Pfizer bets $25M on Zentalis, will support cancer trials April 27, 2022 3:46 am https://www.fiercebiotech.com/biotech/spying-synthetic-lethal-promise-pfizer-bets-wee-25m-zentalis-signs-support-cancer-trials

Zolgensma for dementia? AviadoBio gains orphan tag for one-dose gene therapy April 27, 2022 3:12 am https://www.fiercebiotech.com/biotech/zolgensma-dementia-aviadobio-gains-orphan-designation-one-dose-gene-therapy

Amgen opts to DARP-out after seeing early data from $50M Molecular Partners collab April 26, 2022 12:45 pm https://www.fiercebiotech.com/biotech/amgen-opts-darp-out-after-seeing-early-data-50m-molecular-partners-collab